LONDON (Reuters) - Japan Tobacco International expects a shift towards cheaper cigarette brands in the United States to reach more than 40% of the market by 2027, its finance chief told Reuters. U.S. smokers have been swapping out brands such as Altria's Marlboro and British American Tobacco's (BAT) Newport, which have been raising prices for years, for less expensive brands as high inflation and interest rates stretch their wallets. BAT's U.S. cigarette volumes fell 10.1% last year in part due to this shift, it reported on Thursday, while Altria has also been losing market share. Those companies hope the trend is temporary and will recede as economic pressures ease. But Japan Tobacco International expects pricier brands to continue losing ground even as affordability improves, finance chief Vassilis Vovos told Reuters. "This is a... hard trend and we see it continuing over time," he said, adding steep price increases will continue to push consumers to trade down - a trend visible in many markets where big price gaps emerge. Tobacco giants such as Altria and BAT have relied on increasing prices to support revenue growth in markets like the United States, the world's second largest tobacco market after China, as falling smoking rates have put the industry's volumes into structural decline. JTI, which is part of Japanese conglomerate Japan Tobacco, expects the value and super value segment to account for 42% of the market by 2027, up from around 32% today, Vovos said in an interview the day after the company reported full-year results. JTI completed the acquisition of U.S. tobacco company Vector Group last year, which pushed its share of the super value segment to 40% by the fourth quarter of 2024, its results presentation showed. (Reporting by Emma Rumney; Editing by Susan Fenton) View Comments
Cheap cigarettes will continue taking US market share, tobacco firm JTI predicts
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research.
Start Your Free Trial Now!Not sure where to invest today?
Kalkine’s latest research highlights three companies identified through in-depth analysis and market insights.
Explore these research reports to learn about companies currently being tracked by our analysts and make more informed investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...